(3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide

C53H86N14O10 — CID 155310595

IUPAC(3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide
SMILESCCCCCCC[C@@H](O)CC(=O)N[C@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](Cc2cccnc2)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O
InChIInChI=1S/C53H86N14O10/c1-4-5-6-7-11-16-36(68)31-45(69)60-37(17-22-54)47(71)64-41-21-27-59-46(70)43(30-35-15-12-26-58-32-35)66-49(73)39(19-24-56)61-48(72)38(18-23-55)63-52(76)42(28-33(2)3)65-53(77)44(29-34-13-9-8-10-14-34)67-50(74)40(20-25-57)62-51(41)75/h8-10,12-15,26,32-33,36-44,68H,4-7,11,16-25,27-31,54-57H2,1-3H3,(H,59,70)(H,60,69)(H,61,72)(H,62,75)(H,63,76)(H,64,71)(H,65,77)(H,66,73)(H,67,74)/t36-,37-,38+,39+,40+,41+,42+,43+,44-/m1/s1
InChIKeyYHMBGAXKQGGILI-ZWKDPEGJSA-N
MW1079.36 g/mol
LogP-2.18
Rot. Bonds25

About (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide

(3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide (PubChem CID 155310595) has the molecular formula C53H86N14O10 and a molecular weight of 1079.36 g/mol. Its IUPAC name is (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide.

Molecular Properties

Compound Name(3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide
PubChem CID155310595
Molecular FormulaC53H86N14O10
Molecular Weight1079.36 g/mol
Exact Mass1078.67
IUPAC Name(3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide
SMILESCCCCCCC[C@@H](O)CC(=O)N[C@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](Cc2cccnc2)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O
InChIInChI=1S/C53H86N14O10/c1-4-5-6-7-11-16-36(68)31-45(69)60-37(17-22-54)47(71)64-41-21-27-59-46(70)43(30-35-15-12-26-58-32-35)66-49(73)39(19-24-56)61-48(72)38(18-23-55)63-52(76)42(28-33(2)3)65-53(77)44(29-34-13-9-8-10-14-34)67-50(74)40(20-25-57)62-51(41)75/h8-10,12-15,26,32-33,36-44,68H,4-7,11,16-25,27-31,54-57H2,1-3H3,(H,59,70)(H,60,69)(H,61,72)(H,62,75)(H,63,76)(H,64,71)(H,65,77)(H,66,73)(H,67,74)/t36-,37-,38+,39+,40+,41+,42+,43+,44-/m1/s1
InChIKeyYHMBGAXKQGGILI-ZWKDPEGJSA-N
XLogP-2.18
TPSA399.10 Ų
H-Bond Donors14
H-Bond Acceptors15
Rotatable Bonds25
Heavy Atoms77
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001079.36
LogP ≤ 5-2.18
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide?
The IUPAC name of (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide (CID 155310595) is (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide.
What is the SMILES notation for (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide?
The canonical SMILES for (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide is CCCCCCC[C@@H](O)CC(=O)N[C@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H](Cc2cccnc2)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O.
What is the InChIKey of (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide?
The InChIKey is YHMBGAXKQGGILI-ZWKDPEGJSA-N. The full InChI is InChI=1S/C53H86N14O10/c1-4-5-6-7-11-16-36(68)31-45(69)60-37(17-22-54)47(71)64-41-21-27-59-46(70)43(30-35-15-12-26-58-32-35)66-49(73)39(19-24-56)61-48(72)38(18-23-55)63-52(76)42(28-33(2)3)65-53(77)44(29-34-13-9-8-10-14-34)67-50(74)40(20-25-57)62-51(41)75/h8-10,12-15,26,32-33,36-44,68H,4-7,11,16-25,27-31,54-57H2,1-3H3,(H,59,70)(H,60,69)(H,61,72)(H,62,75)(H,63,76)(H,64,71)(H,65,77)(H,66,73)(H,67,74)/t36-,37-,38+,39+,40+,41+,42+,43+,44-/m1/s1.
What are the key properties of (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide?
(3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide has a molecular weight of 1079.36 g/mol, XLogP of -2.18, 25 rotatable bonds, 14 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-N-[(2R)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3-(pyridin-3-ylmethyl)-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxydecanamide is sourced from PubChem (CID 155310595), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).